Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.43 |
| ▸ | NPY4R | P50391 | 7/20 | 0.39 |
| ▸ | NPY1R | P25929 | 5/20 | 0.39 |
| ▸ | NPY2R | P49146 | 4/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.39 |
| ▸ | OTC | P00480 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 3/20 | 0.38 |
| ▸ | NOS1 | P29475 | 3/20 | 0.38 |
| ▸ | NOS2 | P35228 | 3/20 | 0.38 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.37 |
| ▸ | RRM1 | P23921 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8745865 | 1.00 | DPP7 (0.43) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL8214683 | 1.00 | DPP7 (0.43) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL16421890 | 0.95 | DPP7 (0.46) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL10190380 | 0.95 | DPP7 (0.46) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL13320657 | 0.95 | DPP7 (0.46) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL13434929 | 0.89 | ANPEP (0.37) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL12278048 | 0.89 | ANPEP (0.37) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL8125131 | 0.89 | ANPEP (0.37) | DPP7NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL18542868 | 0.87 | DPP7 (0.44) | DPP7OTCGNAI3GNAO1GNAI1 | |
| SCHEMBL19368710 | 0.87 | DPP7 (0.44) | DPP7OTCGNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024114953-A1 | PHYLLOCHLORIN ANALOGUES SUITABLE FOR USE IN PHOTODYNAMIC THERAPY (PDT) | RMW CHO GROUP LIMITED (CN) | 2024-06-06 | — | — | WO | disclosed |
| US-20230295103-A1 | AURONE DERIVATIVES AND USES THEREOF FOR CONTROLLING BACTERIA AND/OR FUNGI | ECOLE CENTRALE DE MARSEILLE (FR) | 2023-09-21 | — | — | US | disclosed |
| US-20230295103-A1 | AURONE DERIVATIVES AND USES THEREOF FOR CONTROLLING BACTERIA AND/OR FUNGI | ECOLE CENTRALE DE MARSEILLE (FR) | 2023-09-21 | — | — | US | disclosed |
| EP-4219717-A2 | EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY | Sarepta Therapeutics, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20230227420-A1 | PRODRUGS OF MDMA, MDA, AND DERIVATIVES THEREOF | EMPATHBIO, INC. | 2023-07-20 | — | — | US | disclosed |
| US-20230183419-A1 | Biodegradable Copolymers and Nanofibrous Scaffold Thereof | REGENTS OF THE UNIVERSITY OF MICHIGAN | 2023-06-15 | — | — | US | disclosed |
| WO-2023094679-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW CHO GROUP LIMITED (CN) | 2023-06-01 | — | — | WO | disclosed |
| EP-2968080-B1 | ORAL FORMULATION OF POLYGLUCOSAMINE DERIVATIVES IN COMBINATION WITH A NON-FERMENTABLE SUGAR | SYNEDGEN INC (US) | 2023-05-10 | — | — | EP | disclosed |
| WO-2023056102-A1 | NOVEL PRODRUGS OF MDMA, MDA, AND DERIVATIVES THEREOF | ATAI Life Sciences AG (DE) | 2023-04-06 | — | — | WO | disclosed |
| WO-2023015533-A1 | SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 深圳市维琪医药研发有限公司 | 2023-02-16 | — | — | WO | disclosed |
| US-20110190395-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-08-04 | — | — | US | disclosed |
| US-20110166228-A1 | COMPOSITION | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-07-07 | — | — | US | disclosed |
| US-20100280109-A1 | LIPID COMPOUNDS FOR USE IN COSMETIC PRODUCTS, AS FOOD SUPPLEMENT OR AS A MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-11-04 | — | — | US | disclosed |
| US-20100266681-A1 | FATTY ACID ALCOHOLS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-10-21 | — | — | US | disclosed |
| US-20100144655-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-06-10 | — | — | US | disclosed |
| US-20090131328-A1 | FURIN INHIBITORS | SMITH ROBERT E | 2009-05-21 | — | — | US | disclosed |
| US-20080176807-A1 | Facially amphiphilic polymers and oligomers and uses thereof | MIDCAP FINANCIAL SBIC, LP, AS ADMINISTRATIVE AGENT | 2008-07-24 | — | — | US | disclosed |
| US-20080176807-A1 | Facially amphiphilic polymers and oligomers and uses thereof | MIDCAP FINANCIAL SBIC, LP, AS ADMINISTRATIVE AGENT | 2008-07-24 | — | — | US | disclosed |
| WO-2007038172-A2 | GUANIDINIUM CARRIERS | NITTO DENKO CORPORATION (JP) | 2007-04-05 | — | — | WO | disclosed |
| WO-2007001926-A2 | LOW-SWELLING HYDROGEL SEALANTS FOR WOUND REPAIR | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2007-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080176807-A1 | Facially amphiphilic polymers and oligomers and uses thereof | TLR3, ABHD16A, ANTXR2 | DPP7 1846/4885NPY4R 2483/4885NPY1R 2585/4885 |
| US-20110166228-A1 | COMPOSITION | ELOVL3, FFAR3, ALOX5 | DPP7 1830/4885NPY4R 217/4885NPY1R 268/4885 |
| US-20230227420-A1 | PRODRUGS OF MDMA, MDA, AND DERIVATIVES THEREOF | COMT, PNMT, ABCB1 | DPP7 314/4885NPY4R 861/4885NPY1R 1399/4885 |
| US-20090131328-A1 | FURIN INHIBITORS | FURIN, PREP, TMPRSS15 | DPP7 205/4885NPY4R 4051/4885NPY1R 3928/4885 |
| US-20110190395-A1 | NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT | SGMS2, SGMS1, ACSS2 | DPP7 1273/4885NPY4R 1552/4885NPY1R 1417/4885 |
| US-20230295103-A1 | AURONE DERIVATIVES AND USES THEREOF FOR CONTROLLING BACTERIA AND/OR FUNGI | AURKA, CYP51A1, AURKC | DPP7 1466/4885NPY4R 4869/4885NPY1R 4849/4885 |
| US-20100266681-A1 | FATTY ACID ALCOHOLS | ALOX5, ALOX15, ALOX15B | DPP7 2657/4885NPY4R 561/4885NPY1R 1220/4885 |
| US-20100144655-A1 | ORGANIC COMPOUNDS | OAT, MAVS, HAVCR2 | DPP7 824/4885NPY4R 3843/4885NPY1R 4188/4885 |
| US-20100280109-A1 | LIPID COMPOUNDS FOR USE IN COSMETIC PRODUCTS, AS FOOD SUPPLEMENT OR AS A MEDICAMENT | SGMS1, SGMS2, C1S | DPP7 3758/4885NPY4R 1571/4885NPY1R 1038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.